Stockscreener 앱 받기
0.67%
시간 외 거래:
Amgen Inc 주식(AMGN)의 최신 뉴스
Will 340B Lawsuit Over Drug Discounts Shift Amgen's (AMGN) Access Strategy And Investment Narrative? - simplywall.st
Whittier Trust Co. Acquires 39,111 Shares of Amgen Inc. $AMGN - MarketBeat
Sector Gamma AS Increases Position in Amgen Inc. $AMGN - MarketBeat
Investment House LLC Has $7.31 Million Stake in Amgen Inc. $AMGN - MarketBeat
Cullen Frost Bankers Inc. Decreases Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Commerzbank Aktiengesellschaft FI - MarketBeat
Amgen Inc. $AMGN Shares Sold by AMF Tjanstepension AB - MarketBeat
Amgen stock pulled back after a six-day run — here’s what investors watch next week - TechStock²
Amgen (AMGN) Downgraded Amid Competitive Pressures and Uncertain Future - GuruFocus
Y Intercept Hong Kong Ltd Grows Position in Amgen Inc. $AMGN - MarketBeat
Mn Services Vermogensbeheer B.V. Purchases 3,900 Shares of Amgen Inc. $AMGN - MarketBeat
Resona Asset Management Co. Ltd. Lowers Stake in Amgen Inc. $AMGN - MarketBeat
UniSuper Management Pty Ltd Acquires 6,911 Shares of Amgen Inc. $AMGN - MarketBeat
Teacher Retirement System of Texas Decreases Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Strs Ohio - MarketBeat
Peering Into Amgen Inc's Recent Short Interest - Sahm
Assessing Amgen (AMGN) Valuation After The New Sagebrush 340B Lawsuit - simplywall.st
Amgen (AMGN) Faces Downgrade Amidst Promising Pipeline - GuruFocus
Amgen snaps after six straight sessions of gains - MSN
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock - Yahoo Finance
Lockheed Martin Investment Management Co. Makes New $2.62 Million Investment in Amgen Inc. $AMGN - MarketBeat
Analyst recommendations: Amgen, P&G, Spotify, Duolingo, Moderna… - marketscreener.com
Amgen (AMGN) Faces 340B Lawsuit: What Does Sagebrush Dispute Reveal About Its Stakeholder Strategy? - Yahoo Finance
Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
Amgen Faces 340B Lawsuit Spotlighting Drug Pricing And Investor Risks - simplywall.st
Amgen (AMGN) expands obesity strategy with Ro collaboration on GLP-1 therapies - MSN
Amgen (NASDAQ:AMGN) Hits New 1-Year HighHere's Why - MarketBeat
Amgen: A Buy In 2026 On Exciting MariTide ObesityT2D Potential (NASDAQ:AMGN) - Seeking Alpha
Amgen stock hits 52-week high at $346.41 - Investing.com
Sagebrush sues Amgen over 340B program row - The Pharma Letter
Rakuten Investment Management Inc. Purchases Shares of 27,258 Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN) Downgraded by Bernstein on Market Challenges - GuruFocus
Ember LifeSciences Taps Former Amgen Exec as CFO - Contract Pharma
Amgen downgraded at Bernstein on 2026 outlook - MSN
Cell and Gene Therapy Market Innovations and Key Players: Amgen - openPR.com
Johnson & Johnson Clears the Patent Cliff as 2026 Guidance Resets the Narrative - Investing.com
Biocom Announces Powerhouse Keynote Panel Featuring Heads of Discovery and Research & Development from AbbVie, Amgen and Eli Lilly at 2026 Global Partnering & Investor Conference - The AI Journal
Amgen (AMGN) Expands Obesity Strategy With Ro Collaboration on GLP-1 Therapies - Finviz
Amgen's (NASDAQ:AMGN) Shareholders Will Receive A Bigger Dividend Than Last Year - simplywall.st
Amgen (NASDAQ:AMGN) Has Announced That It Will Be Increasing Its Dividend To $2.52 - Yahoo Finance
AMGEN INC (NASDAQ:AMGN) Shows High Technical and Setup Ratings for Potential Breakout - Chartmill
Arkadios Wealth Advisors Increases Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN): Company Profile, Stock Price, News, Rankings - Fortune
Red Biotechnology Market Is Going to Boom 20262023 |Amgen Inc., Gilead Sciences, Inc., Biogen - openPR.com
UBS Raises PT on Amgen Inc. (AMGN) to $326 From $315, Keeps a Neutral Rating - MSN
Lobbying Update: $3,550,000 of AMGEN INC lobbying was just disclosed - Quiver Quantitative
Sagebrush Health Sues Amgen for Over $7 Million in Damages - Intellectia AI
Amgen (AMGN) Downgraded by Bernstein, Price Target Unchanged | A - GuruFocus
Bernstein downgrades Amgen as 2026 lacks near-term catalysts - Investing.com
Sanford C. Bernstein Downgrades Amgen (NASDAQ:AMGN) to Market Perform - MarketBeat
Seizert Capital Partners LLC Trims Stock Position in Amgen Inc. $AMGN - MarketBeat
Pacific Heights Asset Management LLC Has $23.99 Million Holdings in Amgen Inc. $AMGN - MarketBeat
UPS building massive $6 million cooler - The Business Journals
40 Under 40: Melissa Wagner, Amgen - Medical Marketing and Media
A Look At Amgen (AMGN) Valuation After Strong Q3 Results And Pipeline Momentum - Yahoo Finance
Amgen stock hits pause on MLK Day — what to watch before AMGN returns Tuesday - TechStock²
Tradewinds LLC. Makes New $988,000 Investment in Amgen Inc. $AMGN - MarketBeat
Amgen Inc.'s (NASDAQ:AMGN) Intrinsic Value Is Potentially 93% Above Its Share Price - 富途资讯
Beat the Market the Zacks Way: Amicus, Micron, Amgen in Focus - Yahoo Finance
Royal Fund Management LLC Cuts Holdings in Amgen Inc. $AMGN - MarketBeat
3,785 Shares in Amgen Inc. $AMGN Bought by Campbell & CO Investment Adviser LLC - MarketBeat
Allstate Corp Has $5.54 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
DISCO Oncology Pact And MariTide Obesity Data Might Change The Case For Investing In Amgen (AMGN) - simplywall.st
Sequoia Financial Advisors LLC Has $45.33 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. (NASDAQ:AMGN) is largely controlled by institutional shareholders who own 80% of the company - Yahoo Finance
Amgen’s Obesity Drug May Crush Novo Nordisk & Lilly With Just Four Shots A Year! - Smartkarma
WoodTrust Financial Corp Sells 588,232 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stock Position Cut by QRG Capital Management Inc. - MarketBeat
Pinnacle Financial Partners Inc Has $13.66 Million Stake in Amgen Inc. $AMGN - MarketBeat
Assessing Amgen (AMGN) Valuation As Shares Track Close To Analyst Targets - simplywall.st
3.65%
1.72%
자본화:
|
볼륨(24시간):